REDEFINE 1, in adults with overweight or obesity without diabetes, reported 22.7% mean weight loss for the combination at 68 weeks on the on-treatment analysis, with 60% of combination participants reaching at least 20% loss and 23% reaching at least 30% (Aronne et al., 2025)
Summary Keywords molecular screening, bilirubin, favism, hemolytic anemia, neonatal jaundice, peroxiredoxin 2, Heinz bodies, G6PD Citation Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A and Cheah FC (2022) Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity
Specifications Manufacturer: Hospira / Pfizer Volume: 30 mL Form: Clear, colourless sterile solution Container: Sealed vial Category: Laboratory / research supply Packaging: Individually packaged Intended Use Sold for laboratory and research use only
It begins with diagnosis, inflammatory control, mechanical load strategy, and tissue-specific priorities
